HIV PrEP vs PEP: Prevention Options Explained

Two names, one letter apart, completely different jobs. If you have been researching ways to protect yourself from HIV, you have almost certainly run into both PrEP and PEP — and it is easy to blur them together. Understanding PrEP vs PEP HIV prevention options matters because using the wrong one, or using the right one at the wrong time, can leave you unprotected. This guide explains what each one does, who it is for, how well it works, and the newest options available in 2026, so you can talk to a healthcare provider with confidence.

What PrEP Is: Protection Before Exposure

PrEP stands for pre-exposure prophylaxis. It is medication taken by people who do not have HIV to reduce their chances of getting it through sex or injection drug use. The key word is before: PrEP is designed for people with ongoing, anticipated risk, and it keeps a protective level of medicine in the body so that if exposure happens, the virus cannot establish an infection.

PrEP is not a single pill. As of 2026, there are four main ways to take it:

• Daily oral PrEP: One pill taken every day for as long as you remain at risk. This is the original and most widely used form, and it protects against HIV from both sex and injection drug use.
• On-demand PrEP (also called event-driven or 2-1-1): A schedule of pills taken around a specific planned event of potential exposure — two pills before, one pill 24 hours after, and one pill 48 hours after. This approach is recommended only for certain people (for example, some men having anal sex) and is not advised for vaginal sex or injection drug use.
• Long-acting injectable cabotegravir: A shot given by a healthcare provider, starting with two initiation injections one month apart and then one injection every two months. It is an option for people who have difficulty taking a daily pill.
• Long-acting injectable lenacapavir: The newest option, approved in the United States in June 2025 and endorsed by the World Health Organization shortly after. It is given just twice a year, and in clinical trials more than 99.9% of participants who received it remained HIV negative. Because it does not rely on daily pill-taking, it may be transformative for adherence.

The CDC considers PrEP highly effective when taken as prescribed, reducing the risk of getting HIV from sex by about 99% and from injection drug use by at least 74%. It does not protect against other sexually transmitted infections, so condoms remain an important part of a complete prevention plan.

What PEP Is: Emergency Protection After Exposure

PEP stands for post-exposure prophylaxis. It is an emergency course of antiretroviral medication taken after a possible exposure to HIV — for example, after condomless sex with a partner whose HIV status is unknown, a condom breaking, a needlestick injury, or a sexual assault.

PEP is strictly time-sensitive. It must be started within 72 hours (3 days) of the possible exposure, and the sooner the better — ideally within the first 24 hours. After starting, you take the medication once or twice daily for a full 28 days. Missing doses or stopping early can compromise its effectiveness.

Observational studies suggest PEP reduces the risk of HIV from sexual exposure by more than 80% when started promptly and the full course is completed. It is not 100% effective, and it does nothing to protect against future exposures — which is why clinicians typically use a PEP visit as a moment to discuss whether ongoing prevention like PrEP would make sense. For a detailed walkthrough, see our guide to PEP after HIV exposure: what to do in the first 72 hours.

PrEP vs PEP HIV Prevention: Side-by-Side Comparison

The table below distills the differences into the questions people most often ask.

Timing: PrEP is taken before any potential exposure, on an ongoing basis. PEP is taken only after a possible exposure.

Regimen: PrEP is a daily pill, an on-demand pill schedule, or an injection every 2 or 6 months. PEP is a 28-day course of pills, taken once or twice daily.

Time window: PrEP needs to be started ahead of time — oral PrEP takes about 7 days of daily use to reach maximum protection for receptive anal sex and about 21 days for receptive vaginal sex and injection drug use. PEP must be started within 72 hours after exposure.

Purpose: PrEP is for ongoing, anticipated risk. PEP is for a single, specific emergency.

Effectiveness: PrEP is about 99% effective against sexual transmission when taken as prescribed. PEP is highly effective when started early but is not a substitute for a planned prevention strategy, and it offers no protection against exposures that happen afterward.

Follow-up care: People on PrEP need regular check-ins — HIV testing, kidney function monitoring, and STI screening, typically every three months. People who complete PEP need follow-up HIV testing to confirm the outcome.

Repeat use: PrEP is meant to be used for as long as you are at risk. PEP can be taken more than once if needed, but needing PEP repeatedly is a strong signal that you should be considering PrEP instead.

How These Medicines Actually Work

Both PrEP and PEP use antiretroviral drugs — medicines that interfere with HIV’s ability to copy itself inside the body. When HIV enters the body, it needs to hijack your cells’ machinery to reproduce. Antiretrovirals block the enzymes and structures the virus depends on for that process. No reproduction, no established infection.

The difference is one of timing and strategy. With PrEP, the drug is already present in your bloodstream and tissues when the virus shows up, so it can be shut down immediately. With PEP, the drug arrives after the virus has entered, and it must work fast enough to stop the infection from taking hold before the virus embeds itself permanently. That is why the 72-hour window is so strict: the longer the delay, the harder the job becomes. (Lenacapavir, the newest PrEP option, works slightly differently — it attacks the virus’s capsid, the protein shell carrying its genetic material, rather than the copying enzymes other drugs target.)

Who Should Consider PrEP vs Who Needs PEP

PrEP may be worth discussing with your doctor if you:

• Have a sexual partner living with HIV who is not consistently on treatment with a suppressed viral load
• Do not consistently use condoms, or have partners whose HIV status you do not know
• Have been diagnosed with a sexually transmitted infection in the past six months
• Share equipment for injecting drugs
• Are in a serodiscordant relationship (one partner living with HIV, one not) and want added protection

Guidance from public health authorities also notes that it is reasonable to prescribe PrEP to adults who simply ask for it, since not everyone is comfortable disclosing details about their sexual or drug-use behavior to a clinician.

PEP may be needed if you:

• Had condomless sex with a partner whose HIV status is unknown, or who is living with HIV and not on effective treatment
• Experienced a condom breaking or slipping off during sex
• Shared needles or other injection equipment with someone who may have HIV
• Experienced a sexual assault
• Sustained an occupational exposure to blood, such as a needlestick injury

If any of the above happened within the last 72 hours, treat it as urgent: go to an emergency department, urgent care clinic, or sexual health clinic today and say you need to be evaluated for PEP. Every hour counts.

What to Do in the First 72 Hours: A PEP Action Plan

Knowing what to expect can make an already stressful situation easier to navigate:

• Hour 0 — Act immediately. Do not wait to “see how you feel” or to research online. Call your nearest emergency department or sexual health clinic and say you need a PEP evaluation. If you can, go in person.
• At the clinic: A clinician will assess the exposure, order baseline tests, and can often prescribe the first doses the same day. Call ahead if possible to confirm the clinic stocks PEP.
• Days 1–28: Take the medication exactly as directed, without skipping doses. Set phone alarms. If nausea or other side effects appear — the most common are mild nausea, fatigue, headache, and stomach upset — they usually ease within the first week or two; tell your clinician rather than stopping on your own.
• During the course: Keep protecting yourself and others. PEP does not cover future exposures, so use condoms and avoid sharing injection equipment while on it.
• Follow-up testing: Your clinician will schedule HIV tests after you finish the course — typically around 6 weeks and 12 weeks after the exposure — to confirm the outcome. There is no physical sign that PEP “worked”; only the test results tell you.

From PEP to PrEP: When Emergency Care Becomes Ongoing Protection

Finishing a PEP course is not the end of the story if your risk continues. Clinicians consider repeated PEP use one of the clearest indicators that a person should transition to PrEP. If you have needed PEP once and your circumstances have not changed — same patterns of partners, same inconsistent condom use, same occupational exposures — talk to your doctor about starting PrEP before the next emergency.

After completing the 28-day PEP course and confirming you remain HIV negative, a clinician can evaluate you for PrEP and start you on whichever form suits your life — daily pills, an injection every two months, or the twice-yearly option — eliminating the frantic race against the 72-hour clock.

Side Effects and Safety Monitoring

Both PrEP and PEP are generally well tolerated, but it helps to know what to expect.

PrEP side effects: Some people notice mild nausea, headache, or stomach upset when starting daily oral PrEP; these “start-up” symptoms usually fade within a few weeks. Tenofovir-based pills can affect the kidneys and bone density in a small number of long-term users, which is why kidney function is checked before starting and at follow-up visits. Injectable PrEP most commonly causes temporary soreness at the injection site.

PEP side effects: The most common are nausea, fatigue, headache, and digestive upset, usually mild and easing within the first week or two. Serious side effects with current PEP regimens are uncommon.

Ongoing monitoring: PrEP requires an HIV test before starting and periodic retesting, kidney function checks, and STI screening — typically every three months.

PrEP vs PEP Myths and Facts

Myth: PrEP and PEP protect against all STIs. Fact: They protect against HIV only. You can still get chlamydia, gonorrhea, syphilis, and other infections. Regular STI screening and condoms remain important. (A separate strategy, doxyPEP, addresses bacterial STIs — see DoxyPEP explained: what doctors say about STI prevention.)

Myth: You can share PrEP pills with a partner as emergency PEP. Fact: PrEP and PEP use different regimens, and PEP must be started under medical supervision with baseline testing. Sharing medication is unsafe and unreliable.

Myth: PEP works like a morning-after pill you can use whenever. Fact: PEP is an emergency intervention with a strict 72-hour window, a 28-day commitment, and medical follow-up — not a routine or casual option. Repeated emergencies mean you should be on PrEP.

Myth: PrEP is only for certain groups of people. Fact: PrEP is for anyone at ongoing risk of HIV through sex or injection drug use, regardless of gender, orientation, or relationship status. If you are concerned about your risk, you are allowed to ask for it.

Myth: If you are on PrEP, you cannot transmit HIV. Fact: PrEP protects the person taking it from getting HIV. Separately, a person living with HIV who is on effective treatment with a suppressed viral load cannot pass HIV to partners through sex — a fact independent of PrEP.

Cost and Getting Access

Costs vary widely by country, insurance coverage, and generic availability. In many health systems, PrEP is covered by insurance or national programs, and patient-assistance programs exist in several countries to reduce out-of-pocket costs.

You can access both through sexual health clinics, your primary care doctor, and local health departments — and for PEP, hospital emergency departments are usually the fastest option when the clock is ticking. If cost is a concern, call ahead and ask about assistance programs; clinics that specialize in HIV prevention deal with this question every day. The CDC maintains clinical guidance on PrEP at cdc.gov, and a plain-language consumer overview at Let’s Stop HIV Together.

Frequently Asked Questions

Can I use PrEP and PEP at the same time?

No — they serve different purposes and are not combined. PrEP is for people without HIV who face ongoing risk; PEP is a short emergency course after a specific exposure. If you are already taking PrEP correctly, you generally do not need PEP, because you are already protected. If you are not on PrEP and have had a recent exposure, PEP is the appropriate option, and your clinician can discuss starting PrEP afterward.

What happens if I miss a dose of PrEP?

Take it as soon as you remember, unless it is almost time for your next dose — then just continue normally; do not double up. Occasional missed doses lower protection somewhat, but frequent misses meaningfully reduce effectiveness. If missing pills is a pattern, tell your clinician: the injectable options (every 2 months or twice a year) exist precisely for people who struggle with daily pills.

Can I stop PrEP once I start?

Yes. PrEP is not a lifetime commitment — you can stop when your period of risk ends. Talk to your clinician about timing: protection from daily oral PrEP wanes over roughly 7–10 days after stopping, and injectable PrEP lingers for months at declining levels, so your clinician will advise on coverage during that “tail period.”

Is PEP effective after 72 hours?

No. PEP is not recommended beyond 72 hours after exposure because it is unlikely to work once the virus has had that much time to establish itself. If you are past the window, do not take leftover medication on your own — instead, see a clinician promptly to discuss testing, monitoring, and whether PrEP is appropriate going forward.

Do I need a prescription for PrEP or PEP?

Yes. Both require a prescription and medical supervision, including an HIV test before starting PrEP and baseline testing for PEP. In some places, pharmacists can initiate PrEP under specific protocols, but a clinician visit remains the standard path. For PEP, an emergency department or urgent care clinic can evaluate and prescribe same-day.

Can PrEP or PEP cure HIV?

No. Neither cures HIV, and neither is for people who already have HIV — they are prevention tools only. Effective treatment for people living with HIV is a different set of antiretroviral regimens taken for life, which can suppress the virus to undetectable levels.

How often should I get tested for HIV while on PrEP?

Typically every three months, along with kidney function checks and STI screening. After completing PEP, follow-up HIV tests are usually scheduled around 6 weeks and 12 weeks after the exposure. Your clinician will set the exact schedule — keep every appointment, since testing is how you confirm the prevention is working.

This article is for educational purposes only and is not medical advice. HIV prevention decisions should be made with a qualified healthcare provider who can assess your individual risk, order appropriate testing, and prescribe medication safely. If you believe you have been exposed to HIV within the last 72 hours, seek medical care immediately — do not wait.